BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36502094)

  • 1. Investigation of the Suitability of a Commercial Radiation Sensor for Pretherapy Dosimetry of Radioiodine Treatment Patients.
    O'Callaghan J; Cody D; Cooke J
    Sensors (Basel); 2022 Dec; 22(23):. PubMed ID: 36502094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for
    Seo Y; Huh Y; Huang SY; Hernandez-Pampaloni JM; Hawkins RA; Gustafson WC; Vo KT; Matthay KK
    Med Phys; 2019 May; 46(5):2477-2486. PubMed ID: 30761545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Simplified Blood Dose Protocols for the Estimation of the Maximum Tolerable Activity in Thyroid Cancer Patients Undergoing Radioiodine Therapy Using 124I.
    Jentzen W; Bockisch A; Ruhlmann M
    J Nucl Med; 2015 Jun; 56(6):832-8. PubMed ID: 25858042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid method.
    Koral KF; Francis IR; Kroll S; Zasadny KR; Kaminski MS; Wahl RL
    Cancer; 2002 Feb; 94(4 Suppl):1258-63. PubMed ID: 11877754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
    Huang SY; Bolch WE; Lee C; Van Brocklin HF; Pampaloni MH; Hawkins RA; Sznewajs A; DuBois SG; Matthay KK; Seo Y
    Mol Imaging Biol; 2015 Apr; 17(2):284-94. PubMed ID: 25145966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
    Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
    Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid echogenicity: A clue to precise individual dosimetry in radioiodine therapy of hyperthyroidism.
    Marković V; Eterović D; Stipanović P; Punda A
    Med Hypotheses; 2011 Feb; 76(2):153-6. PubMed ID: 20889262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies.
    Hartung-Knemeyer V; Nagarajah J; Jentzen W; Ruhlmann M; Freudenberg LS; Stahl AR; Bockisch A; Rosenbaum-Krumme SJ
    Ann Nucl Med; 2012 Nov; 26(9):723-9. PubMed ID: 22802008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving individualised dosimetry in radioiodine therapy for hyperthyroidism using population biokinetic modelling.
    Melgar Pérez J; Orellana Salas A; Santaella Guardiola Y; Antoranz Callejo JC
    Phys Med; 2019 Jun; 62():33-40. PubMed ID: 31153396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
    Eschner W; Kobe C; Schicha H
    Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy.
    Abuqbeitah M; Demir M; Çavdar İ; Tanyildizi H; Yeyin N; Uslu-Beşli L; Kabasakal L; Işıkcı Nİ; Sönmezoğlu K
    Radiat Environ Biophys; 2018 Nov; 57(4):395-404. PubMed ID: 30298289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer.
    Chen MK; Yasrebi M; Samii J; Staib LH; Doddamane I; Cheng DW
    Thyroid; 2012 Mar; 22(3):304-9. PubMed ID: 22300251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dose assessments in radioiodine (131I) therapy. 1. The necessity for in vivo quantitation and dosimetry in the treatment of carcinoma of the thyroid.
    Schlesinger T; Flower MA; McCready VR
    Radiother Oncol; 1989 Jan; 14(1):35-41. PubMed ID: 2928556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.
    Jentzen W; Balschuweit D; Schmitz J; Freudenberg L; Eising E; Hilbel T; Bockisch A; Stahl A
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2298-306. PubMed ID: 20625723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of external radiation exposure rate from radioiodine-treated hyperthyroid patients and radiation safety considerations.
    Demir M; Kabasakal L; Onsel C
    Nucl Med Commun; 1996 Aug; 17(8):692-5. PubMed ID: 8878129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of Blood Dose in Patients Treated With 131I Using MIRD, Imaging, and Blood Sampling Methods.
    Piruzan E; Haghighatafshar M; Faghihi R; Entezarmahdi SM
    Medicine (Baltimore); 2016 Mar; 95(11):e3154. PubMed ID: 26986171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy.
    Kaptein EM; Levenson H; Siegel ME; Gadallah M; Akmal M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3058-64. PubMed ID: 10999786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH.
    Bacher R; Hohberg M; Dietlein M; Wild M; Kobe C; Drzezga A; Schmidt M
    J Nucl Med; 2019 May; 60(5):631-637. PubMed ID: 30315143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.